Improvement of Patient Experience and Healthcare Providers' Productivity Using Virtual Reality in the Field of Radiation Therapy

November 16, 2020 updated by: Yonsei University
The purpose of this study is to investigate the effect of providing information about radiotherapy using virtual reality and to see whether it would improve the productivity of medical staff, improve patient experience and satisfaction, and reduce patient's anxiety prior to radiotherapy.

Study Overview

Status

Unknown

Conditions

Intervention / Treatment

Detailed Description

All patients enrolled in this study will receive the same routine explanation all radiotherapy patients receive currently. However, prior to the routine explanation, additional detailed information regarding radiotherapy (from simulation to treatment) will be given in two different ways.

VR arm: The patients who are allocated to the VR arm will receive information about radiotherapy via virtual reality.

Printed document arm: The patients who are allocated to the Printed document arm will receive information about radiotherapy via printed document.

Patients will answer the questionnaire related to the anxiety scale related to radiotherapy and measure the vital signs such as blood pressure, pulse rate, and the respiratory rate. Also, patients will answer the questions about radiotherapy to assess the understanding of radiotherapy and questionnaire on hospital satisfaction.

Study Type

Interventional

Enrollment (Anticipated)

196

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Korea
      • Seoul, Korea, Korea, Republic of, 120-752
        • Recruiting
        • Severance Hospital
        • Contact:

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

20 years to 64 years (Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

Female

Description

Inclusion Criteria:

  1. Breast cancer patients who received curative surgery and are planned to receive radiotherapy
  2. Patients with cognitive abilities to receive virtual reality information
  3. Patients who are 20 years old or older

Exclusion Criteria:

  1. Patients who have vision or hearing problems to receive information
  2. Patients who do not agree to this study
  3. Pregnancy, Fetuses / Newborns, Minors, and Deficient Patients
  4. 65 years old or older
  5. Patients who have been treated for dizziness within the last 6 months
  6. Patients who have experienced severe dizziness within the last 6 months when using electronic devices

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Other
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: VR
The patients who are allocated to the VR arm will receive information about radiotherapy via virtual reality
The patients who are allocated to the VR arm will receive information about radiotherapy via virtual reality.
No Intervention: Printed document
The patients who are allocated to the Printed document arm will receive information about radiotherapy via printed document.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Amsterdam Preoperative Anxiety and Information Scale (APAIS)
Time Frame: Prior to receiving the radiotherapy information via VR or printed document

Changes in APAIS Before and After Providing Virtual Reality or Printed Document Information

- APAIS: scale from 1 (not worried at all) to 5 (extremely worried, most anxious)

Prior to receiving the radiotherapy information via VR or printed document
Amsterdam Preoperative Anxiety and Information Scale (APAIS)
Time Frame: 5 minutes after receiving the radiotherapy information via VR or printed document

Changes in APAIS Before and After Providing Virtual Reality or Printed Document Information

- APAIS: scale from 1 (not worried at all) to 5 (extremely worried, most anxious)

5 minutes after receiving the radiotherapy information via VR or printed document

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
State-Trait Anxiety Inventory (STAI)
Time Frame: Prior to receiving the radiotherapy information via VR or printed document
Changes in STAI Before and After Providing Virtual Reality or Printed Document Information
Prior to receiving the radiotherapy information via VR or printed document
State-Trait Anxiety Inventory (STAI)
Time Frame: 5 minutes after receiving the radiotherapy information via VR or printed document
Changes in STAI Before and After Providing Virtual Reality or Printed Document Information
5 minutes after receiving the radiotherapy information via VR or printed document

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

March 13, 2020

Primary Completion (Anticipated)

October 1, 2021

Study Completion (Anticipated)

October 1, 2021

Study Registration Dates

First Submitted

October 21, 2019

First Submitted That Met QC Criteria

October 24, 2019

First Posted (Actual)

October 28, 2019

Study Record Updates

Last Update Posted (Actual)

November 18, 2020

Last Update Submitted That Met QC Criteria

November 16, 2020

Last Verified

November 1, 2020

More Information

Terms related to this study

Other Study ID Numbers

  • 4-2019-0795

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Subscribe